OIA
MBRX icon

OneDigital Investment Advisors’s Moleculin Biotech MBRX Stock Holding History

OneDigital Investment Advisors’s Portfolio MBRX Stock Details MBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1
Closed -$4K – 1221
2018
Q3 		$4K Hold
1
– – ﹤0.01% 949
2018
Q2 		$5K Hold
1
– – ﹤0.01% 1165
2018
Q1 		$5K Hold
1
– – ﹤0.01% 1155
2017
Q4 		$5K Buy
+1
New +$4.33K ﹤0.01% 1085
2017
Q3 		– Sell
-1
Closed -$5K – 1119
2017
Q2 		$5K Buy
+1
New +$2.18K ﹤0.01% 1058

Other funds holding MBRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WIC
Whitegate Investment Counselors Concord, New Hampshire $315M AUM 10.6% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

OneDigital Investment Advisors's MBRX Position: Q4 2018 in Review

OneDigital Investment Advisors sold out of Moleculin Biotech (MBRX) in Q4 2018, closing a stake of 1 share — an estimated $4K sold.

OneDigital Investment Advisors first reported a position in MBRX in Q2 2017 and held it in 5 quarters. The position peaked at $5K in Q2 2018. 20 funds tracked by Wall St. Rank hold MBRX as of Q4 2018.

  • OneDigital Investment Advisors reported no remaining Moleculin Biotech position as of Q4 2018 after selling out during the quarter.
  • OneDigital Investment Advisors sold 1 Moleculin Biotech share in Q4 2018, an estimated $4K.
  • OneDigital Investment Advisors first reported a position in Moleculin Biotech in Q2 2017 and held it in 5 quarters.
  • OneDigital Investment Advisors's Moleculin Biotech position peaked at $5K in Q2 2018.
  • 20 funds tracked by Wall St. Rank held Moleculin Biotech as of Q4 2018.

Based on OneDigital Investment Advisors's 13F filing for Q4 2018, filed 12 Feb 2019.